Project Grant R44GM159290
Award Date
5/1/23
Completion Date
7/31/26
Dollars Obligated
$1.1M
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
San Diego, CA 92121, USA
Similar Awards
The Alida Biosciences Inc. was awarded a $765,105 Project Grant from the National Institutes of Health National Human Genome Research Institute under the Human Genome Research federal grant program (CFDA 93.172) on August 17, 2021 to complete work by February 28, 2022. The grant funds the development of a new approach to analyze RNA modifications across entire transcriptomes in a multiplexed reaction at near single-base resolution. Currently available methods either lack sequence context or...
This $350,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) aims to develop the first technology capable of high-accuracy sequencing of the RNA modifications pseudouridine (Ψ) and N6-methyladenosine (m6A). This collaborative effort between academia and industry will merge innovative bisulfite adduct methodology with an enzyme-free, multipass nanopore nucleic acid characterization...
This $256,000 National Science Foundation Engineering grant supports the development of an easy RNA adenylation method for deep sequencing of picogram RNA samples with high resolution. Specifically, Ezrabio Inc. will develop a versatile and cost-effective library construction technology that enables protein translation monitoring on a variety of biological samples. The proposed technology relies on a novel enzyme system capable of 5' adenylation and 3' polyadenylation of RNA fragments to...
This Project Grant award, valued at $215,088.00 and funded by the National Institutes of Health's National Human Genome Research Institute (CFDA 93.172 - Human Genome Research), supports the development of an "Exhaustive De Novo Sequencing of Every RNA in a Sample by a Layer-by-Layer Mass Spectrometry Ladder Intensity Approach" at Directseq Biosciences, Inc. The project aims to 1) further develop a next-generation mass spectrometry-based RNA sequencing method that can comprehensively...
This $406,500 Project Grant award from the National Human Genome Research Institute (NHGRI), under the Human Genome Research Federal Grant Program (CFDA 93.172), aims to advance next-generation mass spectrometry-based sequencing (NGMS-SEQ) methods for comprehensive, unbiased sequencing and quantitative mapping of RNA modifications. The key objectives are to: 1) Increase the throughput of NGMS-SEQ to directly sequence various physiologically relevant tRNA samples, and 2) Enhance the...
This federal Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $303,445 to Endura Therapeutics Inc. to develop a next-generation sequencing platform for discovering small molecules that target RNA. The project aims to demonstrate that small molecules can modulate protein expression by binding to messenger RNA, and to create a high-throughput screening method to identify such molecules and their optimal RNA...
The National Human Genome Research Institute (NHGRI) awarded a $383,482 Project Grant under the Human Genome Research federal grant program (CFDA 93.172) to Electronic Biosciences, Inc., a small biotechnology company in San Diego, California. The grant, awarded on June 6, 2025, aims to develop SPINSEQ, an innovative platform designed to deliver highly precise and accurate RNA sequencing. The project will focus on maintaining RNA integrity and ensuring precise sequencing, with a particular...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) grant awarded to Multitarga LLC for $304,995 will develop an "adaptive multi-targeted priming" technology to enhance the detection of low-abundance pathogen transcripts in complex host-pathogen samples. The project, titled "Adaptive Multi-Targeted Priming for Host-Pathogen Transcriptomics: Leveraging Graph Representation Learning for...
This $3.7 million project grant from the National Institutes of Health's National Institute of Biomedical Imaging and Bioengineering will fund research at Arizona State University to develop RNA stabilizing elements that improve coronavirus diagnostics. Specifically, the university will model the role of 5' secondary structures in modulating mRNA stability, optimize sensing RNAs to detect SARS-CoV-2, and use degradable trans-acting RNAs to enhance sample and amplified RNA stability....
The National Institute of General Medical Sciences (NIGMS) awarded a $307,257 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Sxrna Technologies, Inc. The grant, titled "SXRNA-SELECT: USING RNAS FOR POSITIVE SELECTION OF CELL LINES, ENABLING HIGH-YIELD BIOTHERAPEUTIC PRODUCTION", aims to develop a rapid cell cloning technology called SXRNA-SELECT that will decrease the time and cost of producing biotherapeutic proteins. The project will optimize the...